Le latterie cooperative nella provincia di Belluno / Emilio Morpurgo

Le latterie cooperative nella provincia di Belluno / Emilio Morpurgo Belluno : G. De Liberali, 1884 34 p. ; 24 cm

Della crisi economico-agraria dell'Istria

Università degli Studi di Triest

La finanza : studii di economia pubblica e di statistica comparata

La finanza : studii di economia pubblica e di statistica comparata / Emilio Morpurgo Firenze : Succ. Le Monnier, 1877 LXXXVIII, 192 p., [2] c. di tav. ripieg. ; 19 cm Contenuto indicato sul front.: La finanza e lo Stato, La finanza italiana, Appendici

Danubio. saggio storico-critico della questione danubiana

Danubio : saggio storico-critico della questione danubiana / Emilio Morpurgo. - Bologna : L. Cappelli, stampa 1923 Dedica manoscritta dell'autore: Al Prof. Emilio Bodrero / omaggio / Emilio Morpurgo https://galileodiscovery.unipd.it/discovery/fulldisplay?context=L&vid=39UPD_INST:VU1&search_scope=MyInst_and_CI&tab=Everything&docid=alma99001284758020604

Marco Foscarini e Venezia nel secolo XVIII,

"Scritti di Marco Foscarini": p. [277]-344. "Documenti": p. [345]-433.Mode of access: Internet

More Favorable Short and Long-Term Outcomes for Screen-Detected Colorectal Cancer Patients

Background: Screening significantly reduces mortality from colorectal cancer (CRC). Screen detected (SD) tumors associate with better prognosis, even at later stage, compared to non-screen detected (NSD) tumors. We aimed to evaluate the association between diagnostic modality (SD vs. NSD) and short- and long-term outcomes of patients undergoing surgery for CRC. Materials and Methods: This retrospective cohort study involved patients aged 50–69 years, residing in Veneto, Italy, who underwent curative-intent surgery for CRC between 2006 and 2018. The clinical multi-institutional dataset was linked with the screening dataset in order to define diagnostic modality (SD vs. NSD). Short- and long-term outcomes were compared between the two groups. Results: Of 1,360 patients included, 464 were SD (34.1%) and 896 NSD (65.9%). Patients with a SD CRC were more likely to have less comorbidities (p = 0.013), lower ASA score (p = 0.001), tumors located in the proximal colon (p = 0.0018) and earlier stage at diagnosis (p < 0.0001). NSD patients were found to have more aggressive disease at diagnosis, higher complication rate and higher readmission rate due to surgical complications (all p < 0.05). NSD patients had a significantly lower Disease Free Survival and Overall Survival (all p < 0.0001), even after adjusting by demographic, clinic-pathological, tumor, and treatment characteristics. Conclusions: SD tumors were associated with better long-term outcomes, even after multiple adjustments. Our results confirm the advantages for the target population to participate in the screening programs and comply with their therapeutic pathways

How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group

Since March 2020, the outbreak of Sars-CoV-2 pandemic has changed medical practice and daily routine around the world. Huge efforts from pharmacological industries have led to the development of COVID-19 vaccines. In particular two mRNA vaccines, namely the BNT162b2 (Pfizer-BioNTech) and the mRNA-1273 (Moderna), and a viral-vectored vaccine, i.e. ChAdOx1 nCoV-19 (AstraZeneca), have recently been approved in Europe. Clinical trials on these vaccines have been published on the general population showing a high efficacy with minor adverse events. However, specific data about the efficacy and safety of these vaccines in patients with immune-mediated inflammatory diseases (IMIDs) are still lacking. Moreover, the limited availability of these vaccines requires prioritizing some vulnerable categories of patients compared to others. In this position paper, we propose the point of view about the management of COVID-19 vaccination from Italian experts on IMIDs and the identification of high-risk groups according to the different diseases and their chronic therapy